Longeveron LGVN
NASDAQ LGVN
$3.30 +0.46 (+16.20%)
At close: Nov 11, 2026 · 4:00 PM EST

Longeveron (LGVN) Notes Payables (2020 - 2023)

Updated

Longeveron's Notes Payables came in at $457,000 for Q1 2023, down 73.9% from the prior quarter.

Analysis

Longeveron (LGVN) Notes Payables (2020 - 2023) Analysis & Trends

At the end of FY2022, Longeveron's Notes Payables was $1.75 million, up 171.5% from FY2021.

  • Going back by year, Notes Payables was $645,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Longeveron 8.60 Mn -31.21 Mn 182,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 457,000.00
Dec 31, 2022 1.75 Mn
Dec 31, 2021 645,000.00
Mar 31, 2021 19,000.00
Dec 31, 2020 38,000.00
API Access

Longeveron Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=LGVN&period=max&api_key=YOUR_API_KEY